Healthcare - Biotechnology - NASDAQ - US
$ 0.365
-8.06 %
$ 3.26 M
Market Cap
-0.1
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
33.55%
Net Income
Estimate
--133.97%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Enveric Biosciences, Inc.
ENVB has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart ENVB
EBIT FORECAST
EBIT Forecast Chart ENVB
NET INCOME FORECAST
Net Income Chart ENVB